http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102080996-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10041 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
filingDate | 2018-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102080996-B1 |
titleOfInvention | Cancer cell specific adenovirus |
abstract | The present invention relates to adenovirus that can specifically infect cancer cells to fluoresce and to separate and cultivate cancer cells without killing cancer cells. The adenoviruses of the present invention can penetrate well even when E1 is deleted, and cancer cells in blood. Only by specifically infecting and expressing fluorescently, unlike conventional cancer-specific adenovirus killing cancer cells, it is possible to culture even after separation without killing circulating tumor cells, so that cancer cells can be detected and circulated tumor Isolation and culture of cells, diagnosis of primary cancer, and the selection of anti-cancer drugs that are specific to each individual are effective. |
priorityDate | 2018-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.